Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Non Operating Income: 2017-2025

Historic Non Operating Income for Arcus Biosciences (RCUS) over the last 8 years, with Sep 2025 value amounting to $7.0 million.

  • Arcus Biosciences' Non Operating Income fell 46.15% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year decrease of 28.57%. This contributed to the annual value of $48.0 million for FY2024, which is 23.08% up from last year.
  • According to the latest figures from Q3 2025, Arcus Biosciences' Non Operating Income is $7.0 million, which was down 12.50% from $8.0 million recorded in Q2 2025.
  • Arcus Biosciences' 5-year Non Operating Income high stood at $13.0 million for Q2 2024, and its period low was $154,000 during Q1 2021.
  • Its 3-year average for Non Operating Income is $10.2 million, with a median of $10.0 million in 2025.
  • As far as peak fluctuations go, Arcus Biosciences' Non Operating Income slumped by 76.20% in 2021, and later spiked by 4,088.48% in 2023.
  • Over the past 5 years, Arcus Biosciences' Non Operating Income (Quarterly) stood at $519,000 in 2021, then spiked by 1,248.75% to $7.0 million in 2022, then spiked by 57.14% to $11.0 million in 2023, then declined by 9.09% to $10.0 million in 2024, then tumbled by 46.15% to $7.0 million in 2025.
  • Its Non Operating Income stands at $7.0 million for Q3 2025, versus $8.0 million for Q2 2025 and $10.0 million for Q1 2025.